0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,500USDGBP
Global Ferrous Sulfate - Procurement Market Intelligence Report - Product Thumbnail Image

Global Ferrous Sulfate - Procurement Market Intelligence Report

  • Report
  • October 2018
  • 106 Pages
  • Global
From
EUR$2,500USDGBP
Drug Overview: Zoladex - Product Thumbnail Image

Drug Overview: Zoladex

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
EUR$10,000USDGBP
Drug Overview: NeoRecormon - Product Thumbnail Image

Drug Overview: NeoRecormon

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
EUR$10,000USDGBP
Xarelto - API Insight, 2022 - Product Thumbnail Image

Xarelto - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Lovenox With Preservative - API Insight, 2022 - Product Thumbnail Image

Lovenox With Preservative - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Venoferrum - API Insight, 2022 - Product Thumbnail Image

Venoferrum - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
BeneFIX - API Insight, 2022 - Product Thumbnail Image

BeneFIX - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more